See also this year's filing and all EDGAR filings for this company.
PDF Report 0000886163_2023_LIGAND_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000886163, LIGAND PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 263,601,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 448,128,000 |
| 2 | PropertyPlantAndEquipmentNet | 12,482,000 |
| 3 | remainder_Assets | 38,457,000 |
| 4 | LiabilitiesCurrent | 98,810,000 |
| 5 | LiabilitiesNoncurrent | 32,302,000 |
| 6 | remainder_Liabilities | 34,071,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 70,062,000 |
| 9 | ResearchAndDevelopmentExpense | 36,082,000 |
| 10 | remainder_Expenses | 128,294,000 |
| 11 | remainder_Revenues | 196,245,000 |
| 12 | remainder_NetIncome | 4,832,000 |
| 13 | remainder_ComprehensiveNetIncome | -67,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 762,668,000 |
| 1 | Liabilities | 165,183,000 |
| 2 | Expenses | 234,438,000 |
| 3 | Revenues | 196,245,000 |
| 4 | StockholdersEquity | 597,485,000 |
| 5 | NetIncome | -33,361,000 |
| 6 | ComprehensiveNetIncome | -33,394,500 |
| 7 | BaseVar | 681,716,500 |
| 8 | EconomicCapitalRatio | 2.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
